系统性红斑狼的Telitacicept:系统性审查和元分析的协议
Xiangge Ren1,2, Peidong Zhao1,2, Jiawei Zhang1,2
1Department of Pediatrics, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
BMJ open
|July 16, 2025
概括
这一系统性审查将评估telitacicept用于治疗全身性红斑狼 (SLE). 它旨在通过分析临床结果和免疫参数来确定该药物在SLE患者中的有效性和安全性.
科学领域:
- 免疫学和风湿病学
- 药理学和药物开发领域
背景情况:
- 系统性红斑狼 (SLE) 是一种慢性,多系统的自身免疫性疾病,具有显著的死亡率.
- 泰利塔西通过向B细胞成熟,增殖和分化来减少SLE疾病活动,提供了一种新的治疗方法.
研究的目的:
- 系统地评估telitacicept在全身性红斑狼 (SLE) 患者的疗效和安全性.
- 综合证据,对telitacicept对SLE疾病活动,爆发,器官损伤和免疫标志物的影响.
主要方法:
- 在2025年6月1日之前,将对多个英语和中文数据库进行全面搜索.
- 使用标准化工具进行独立研究选择,数据提取和质量评估 (偏差风险2,ROBINS-I,GRADE).
- 使用随机效应或固定效应模型进行元分析,以汇集临床和实验室结果的数据,并进行子组和灵敏度分析.
主要成果:
- 审查将量化二分结果的风险比率和连续结果的平均值/标准化平均值差异.
- 评估疾病活动,爆发,器官损伤,免疫参数和与特利塔cept治疗相关的不良事件.
- 证据的确定性将使用GRADE系统进行评估.
结论:
- 这一系统性审查将提供关键的证据,以证实teletacicept在SLE管理中的有效性和安全性.
- 这些发现将为临床决策提供信息,并指导未来对新型SLE治疗方法的研究.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
237
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
237
01:26Nephrotic Syndrome II : Assessment and Medical Management
23
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
23